Cronos Group's stock has seen some fluctuations, reflecting both market dynamics and company news.
This week, Cronos Group Inc (CRON.TO) experienced a slight decline, closing at C$4.68, down 0.43% for the day and 1.69% over the past week. Despite this, the stock has shown a positive trend over the past month, gaining nearly 18% year-to-date. Let's delve into the latest developments and market indicators surrounding Cronos Group.
Advertisement
Cronos Group Inc
CRON.TO
CRON.TO
Cronos Group Inc
WealthAwesomeMarket cap
$1.72B
P/E
18.0x
52W high
$4.99
52W low
$3.23
1W change
-1.69%
Beta
1.24
Analyst Price Targets
Based on analyst covering CRON
Wall Street analysts forecast CRON stock price to rise 5.7% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$4.92
+5.7% Upside
Current Price
C$4.66
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRON's historical volatility
30-Day Vol
49.8%
Annualized
90-Day Vol
39.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$5.57
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$4.95 | C$4.17 โ C$5.87 |
| 60 trading days | C$5.25 | C$4.12 โ C$6.69 |
| 90 trading days | C$5.57 | C$4.14 โ C$7.50 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Cronos Group's stock has had a modest pullback recently, its overall performance remains strong, especially in the context of its year-to-date gains. Investors may want to keep an eye on the company's upcoming initiatives and market reactions.
C$4.68 closing price with a 1D decline of 0.43%
The stock is currently trading within 82% of its 52-week range of C$3.23 to C$4.99, indicating it is near its upper limit for the year.
Bull case
Cronos Group has shown strong revenue growth, with a notable 47% increase in Q4 2025 compared to the previous year. This growth, along with a healthy profit margin of 39.1%, positions the company well in the health care sector.
Bear case
Despite these positive indicators, Cronos Group's stock has faced recent declines amid broader market volatility. The current trading volume is below the 20-day average, suggesting reduced investor activity and caution among traders.
Recent Price Action
This week, Cronos Group Inc's stock closed at C$4.68, reflecting a minor decline of 0.43% in one day and a 1.69% decrease over the week. Despite the recent downturn, the stock has shown resilience with a month-to-date increase of approximately 17.97% and a year-to-date growth of 26.29%.
Company News and Developments
Advertisement
There has been limited news coverage surrounding Cronos Group in recent months. The latest headlines include the company's announcement of record net revenue for Q4 and FY 2025, with a significant 47% year-over-year increase. Additionally, Cronos has appointed ATB Capital Markets as its broker for share repurchases, demonstrating a commitment to returning value to shareholders.
Technical Picture
Cronos Group's stock is currently trading above its 50-day moving average of C$4.12 and its 200-day moving average of C$3.76, indicating a bullish trend. The stock is situated within 82% of its 52-week range of C$3.23 to C$4.99. With a beta of 1.24, the stock exhibits slightly higher volatility compared to the market. The latest trading volume of 150,572 shares is below the 20-day average volume of 238,704 shares, suggesting a cautious sentiment among investors.
Insider Activity
Currently, there are no reported insider activities that could impact Cronos Group's stock performance.
Price Action Summary
Cronos Group Inc closed at C$4.68, reflecting a 1D decline of 0.43%. Investors may want to monitor future developments as the company continues to navigate the health care sector.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
